New York Life Investment Management LLC Repligen Corp Transaction History
New York Life Investment Management LLC
- $9.63 Billion
- Q3 2024
A detailed history of New York Life Investment Management LLC transactions in Repligen Corp stock. As of the latest transaction made, New York Life Investment Management LLC holds 6,017 shares of RGEN stock, worth $951,528. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,017
Previous 6,362
5.42%
Holding current value
$951,528
Previous $801,000
11.74%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
489Shares Held
54.3MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.2 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.01 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$798 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$257 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$225 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.78B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....